Skip to main content
Top
Published in: Dermatology and Therapy 2/2022

Open Access 01-02-2022 | Vulgar Psoriasis | Original Research

Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis

Authors: Julia Nowowiejska, Anna Baran, Paulina Grabowska, Marta Lewoc, Tomasz W. Kaminski, Iwona Flisiak

Published in: Dermatology and Therapy | Issue 2/2022

Login to get access

Abstract

Introduction

Psoriasis is a chronic, autoimmune, inflammatory skin disease affecting 2–4% of the general population, which nowadays is even perceived as a systemic illness. The nature of this dermatosis may negatively influence patients’ general condition, life expectancy, and quality of life, which highlights the severity of the problem and the need to perform further investigation. We aimed to assess quality of life, stress severity, and physical activity of patients with psoriasis in relation to demographic and clinical data and comparison to the control group without dermatoses.

Methods

A set of surveys was conducted in 56 patients with psoriasis hospitalized at the Department of Dermatology, Medical University of Bialystok. Questionnaires used involved the Dermatology Life Quality Index, WHO Quality of Life questionnaire, International Questionnaire of Physical Activity, and a self-invented stress survey. Obtained data were compared to a sex- and age-matched control group without dermatoses. Statistical analysis was performed using GraphPad Prism.

Results

Patients with psoriasis were found to be significantly less satisfied with their health and had lower scores in WHO social, environmental, and psychological domains, comparing to controls. Patients reported higher stress severity and lower satisfaction with sex life and physical appearance than controls. Patients with psoriasis also tended to perform less intensive physical activity than controls.

Conclusions

This study highlights the perception of psoriasis as not only affecting skin but also having a multifactorial impact on psychological and internal condition. Described lifestyle abnormalities can be easily evaluated with validated questionnaires, which could be introduced to patients in order to raise their awareness of comorbidities and mobilize them to modify incorrect lifestyle habits. Screening for other disorders and introduction of a holistic approach to every patient could be beneficial because the improvement of patients’ life quality is one of the most important issues.
Literature
1.
go back to reference Gupta MA, Simpson FC, Gupta AK. Psoriasis and sleep disorders: a systematic review. Sleep Med Rev. 2016;29:63–75.CrossRef Gupta MA, Simpson FC, Gupta AK. Psoriasis and sleep disorders: a systematic review. Sleep Med Rev. 2016;29:63–75.CrossRef
2.
go back to reference Chabros P, Pietrzak A, Gągała J, Kandzierski G, Krasowska D. Psoriatic arthritis—classification, diagnostic and clinical aspects. Dermatol Rev. 2020;107:32–43.CrossRef Chabros P, Pietrzak A, Gągała J, Kandzierski G, Krasowska D. Psoriatic arthritis—classification, diagnostic and clinical aspects. Dermatol Rev. 2020;107:32–43.CrossRef
3.
go back to reference Nowowiejska J, Baran A, Krahel J, Flisiak I. Acrodermatitis continua Hallopeau. Dermatol Rev. 2021;108:52–8.CrossRef Nowowiejska J, Baran A, Krahel J, Flisiak I. Acrodermatitis continua Hallopeau. Dermatol Rev. 2021;108:52–8.CrossRef
4.
go back to reference Ryan C, Kirby B. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatol Clin. 2015;33:41–55.CrossRef Ryan C, Kirby B. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatol Clin. 2015;33:41–55.CrossRef
5.
go back to reference Nowowiejska J, Baran A, Flisiak I. Psoriasis and cardiometabolic disorders. Dermatol Rev. 2020;107:508–20.CrossRef Nowowiejska J, Baran A, Flisiak I. Psoriasis and cardiometabolic disorders. Dermatol Rev. 2020;107:508–20.CrossRef
6.
go back to reference Nowowiejska J, Baran A, Flisiak I. Aberrations in lipid expression and metabolism in psoriasis. Int J Mol Sci. 2021;22:6561.CrossRef Nowowiejska J, Baran A, Flisiak I. Aberrations in lipid expression and metabolism in psoriasis. Int J Mol Sci. 2021;22:6561.CrossRef
7.
go back to reference Wilson PB, Bohjanen KA, Ingraham SJ, Leon AS. Psoriasis and physical activity: a review. J Eur Acad Dermatol Venereol. 2012;26:1345–53.CrossRef Wilson PB, Bohjanen KA, Ingraham SJ, Leon AS. Psoriasis and physical activity: a review. J Eur Acad Dermatol Venereol. 2012;26:1345–53.CrossRef
8.
go back to reference Martínez-Ortega JM, Nogueras P, Muñoz-Negro JE, Gutiérrez-Rojas L, González-Domenech P, Gurpegui M. Quality of life, anxiety and depressive symptoms in patients with psoriasis: a case-control study. J Psychosom Res. 2019;124:109780.CrossRef Martínez-Ortega JM, Nogueras P, Muñoz-Negro JE, Gutiérrez-Rojas L, González-Domenech P, Gurpegui M. Quality of life, anxiety and depressive symptoms in patients with psoriasis: a case-control study. J Psychosom Res. 2019;124:109780.CrossRef
9.
go back to reference Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146:891–5.PubMedPubMedCentral Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146:891–5.PubMedPubMedCentral
10.
go back to reference Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401–7.CrossRef Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401–7.CrossRef
11.
go back to reference Nowowiejska J, Baran A, Lewoc M, Grabowska P, Kaminski TW, Flisiak I. The assessment of risk and predictors of sleep disorders in patients with psoriasis—a questionnaire-based cross-sectional analysis. J Clin Med. 2021;10:664.CrossRef Nowowiejska J, Baran A, Lewoc M, Grabowska P, Kaminski TW, Flisiak I. The assessment of risk and predictors of sleep disorders in patients with psoriasis—a questionnaire-based cross-sectional analysis. J Clin Med. 2021;10:664.CrossRef
12.
go back to reference Nowowiejska J, Baran A, Flisiak I. Sleep disorders in psoriasis. Dermatol Rev. 2020;107:272–80.CrossRef Nowowiejska J, Baran A, Flisiak I. Sleep disorders in psoriasis. Dermatol Rev. 2020;107:272–80.CrossRef
13.
go back to reference Mansouri P, Valirad F, Attarchi M, et al. The relationship between disease, work and sickness absence among psoriasis patients. Iran J Public Health. 2015;44(11):1506–13.PubMedPubMedCentral Mansouri P, Valirad F, Attarchi M, et al. The relationship between disease, work and sickness absence among psoriasis patients. Iran J Public Health. 2015;44(11):1506–13.PubMedPubMedCentral
14.
go back to reference Nowowiejska J, Baran A, Flisiak I. Mutual relationship between sleep disorders, quality of life and psychosocial aspects in patients with psoriasis. Front Psychiatry. 2021;12:674460.CrossRef Nowowiejska J, Baran A, Flisiak I. Mutual relationship between sleep disorders, quality of life and psychosocial aspects in patients with psoriasis. Front Psychiatry. 2021;12:674460.CrossRef
18.
go back to reference Hale AJ, Ricotta DN, Freed J, Smith CC, Huang GC. Adapting Maslow’s hierarchy of needs as a framework for resident wellness. Teach Learn Med. 2018;31:109–18.CrossRef Hale AJ, Ricotta DN, Freed J, Smith CC, Huang GC. Adapting Maslow’s hierarchy of needs as a framework for resident wellness. Teach Learn Med. 2018;31:109–18.CrossRef
19.
go back to reference Łakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezińska-Wcisło L. How does stigma affect people with psoriasis? Adv Dermatol Alergol. 2017;34:36–41.CrossRef Łakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezińska-Wcisło L. How does stigma affect people with psoriasis? Adv Dermatol Alergol. 2017;34:36–41.CrossRef
20.
go back to reference Alariny AF, Farid CI, Elweshahi HM, Abbood SS. Psychological and sexual consequences of psoriasis vulgaris on patients and their partners. J Sex Med. 2019;16:1900–11.CrossRef Alariny AF, Farid CI, Elweshahi HM, Abbood SS. Psychological and sexual consequences of psoriasis vulgaris on patients and their partners. J Sex Med. 2019;16:1900–11.CrossRef
21.
go back to reference Hirotsu C, Rydlewski M, Araujo MS, Tufik S, Andersen ML. Sleep loss and cytokines levels in an experimental model of psoriasis. PLoS ONE. 2012;7:51183.CrossRef Hirotsu C, Rydlewski M, Araujo MS, Tufik S, Andersen ML. Sleep loss and cytokines levels in an experimental model of psoriasis. PLoS ONE. 2012;7:51183.CrossRef
22.
go back to reference Elmets CA, Leonardi CL, Davis DMR, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. JAAD. 2019;80:1073–113.CrossRef Elmets CA, Leonardi CL, Davis DMR, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. JAAD. 2019;80:1073–113.CrossRef
23.
go back to reference Rousset L, Halioua B. Stress and psoriasis. Int J Dermatol. 2018;57:1165–72.CrossRef Rousset L, Halioua B. Stress and psoriasis. Int J Dermatol. 2018;57:1165–72.CrossRef
24.
go back to reference Torres T, Alexandre JM, Mendonça D, Vasconcelos C, Silva BM, Selores M. Levels of physical activity in patients with severe psoriasis: a cross-sectional questionnaire study. Am J Clin Dermatol. 2014;15:129–35.CrossRef Torres T, Alexandre JM, Mendonça D, Vasconcelos C, Silva BM, Selores M. Levels of physical activity in patients with severe psoriasis: a cross-sectional questionnaire study. Am J Clin Dermatol. 2014;15:129–35.CrossRef
25.
go back to reference Naldi L, Conti A, Cazzaniga S, Patrizi A, Pazzaglia M, Lanzoni A. Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol. 2014;170:634–42.CrossRef Naldi L, Conti A, Cazzaniga S, Patrizi A, Pazzaglia M, Lanzoni A. Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol. 2014;170:634–42.CrossRef
26.
go back to reference Frankel HC, Han J, Li T, et al. The association between physical activity and the risk of incident psoriasis. Arch Dermatol. 2012;148:918–24.PubMedPubMedCentral Frankel HC, Han J, Li T, et al. The association between physical activity and the risk of incident psoriasis. Arch Dermatol. 2012;148:918–24.PubMedPubMedCentral
Metadata
Title
Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis
Authors
Julia Nowowiejska
Anna Baran
Paulina Grabowska
Marta Lewoc
Tomasz W. Kaminski
Iwona Flisiak
Publication date
01-02-2022
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 2/2022
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-021-00662-1

Other articles of this Issue 2/2022

Dermatology and Therapy 2/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.